ATNF vs REGN: Which Stock is Better?

Side-by-side comparison of 180 Life Sciences Corp and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ATNF

180 Life Sciences Corp

REGN

Regeneron Pharmaceuticals Inc

$635.45

Key Metrics Comparison

MetricATNFREGNWinner
Market Cap$1.08B$59.10BREGN
P/E RatioN/A13.91REGN
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze ATNF

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ATNF or REGN a better investment?

Comparing ATNF and REGN: 180 Life Sciences Corp has a market cap of $1.08B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ATNF and REGN?

ATNF (180 Life Sciences Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ATNF or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ATNF or REGN?

Both ATNF and REGN show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: ATNF or REGN?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: ATNF or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $1.08B for ATNF.

Should I buy ATNF or REGN in 2026?

Both ATNF and REGN have investment merit. ATNF trades at $N/A while REGN trades at $635.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ATNF and REGN stock?

Key differences: Market Cap ($1.08B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy ATNF or REGN in 2026?

The choice between ATNF and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between ATNF and REGN?

ATNF (180 Life Sciences Corp) has a market cap of $1.08B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.

Popular Stock Comparisons